Taro Pharmaceutical Industries shares owned by Northern Trust
Quarter-by-quarter ownership of Taro Pharmaceutical Industries (TARO) shares owned by Northern Trust
from 13F filings
Historical chart of Northern Trust investment in Taro Pharmaceutical Industries
Tip: Access up to 7 years of quarterly data
All positions including Taro Pharmaceutical Industries held by Northern Trust consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Taro Pharmaceutical Industries by Northern Trust
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $2.3M | 55k | 42.34 |
| 2023-09-30 | $2.2M | 58k | 37.71 |
| 2023-06-30 | $2.2M | 57k | 37.93 |
| 2022-06-30 | $409k | 11k | 36.09 |
| 2022-03-31 | $907k | 21k | 43.32 |
| 2021-12-31 | $3.6M | 72k | 50.10 |
| 2021-09-30 | $4.7M | 74k | 63.63 |
| 2021-06-30 | $6.7M | 94k | 71.95 |
| 2021-03-31 | $7.1M | 99k | 71.43 |
| 2020-12-31 | $15M | 199k | 73.42 |
| 2020-09-30 | $11M | 192k | 54.85 |
| 2020-06-30 | $8.7M | 131k | 66.49 |
| 2020-03-31 | $3.7M | 61k | 61.18 |
| 2019-12-31 | $5.4M | 61k | 87.93 |
| 2019-09-30 | $4.4M | 58k | 75.45 |
| 2019-06-30 | $4.5M | 53k | 85.41 |
| 2019-03-31 | $5.8M | 54k | 108.10 |
| 2018-12-31 | $5.0M | 59k | 84.43 |
| 2018-09-30 | $8.0M | 81k | 98.30 |
| 2018-06-30 | $9.7M | 84k | 115.66 |
| 2018-03-31 | $5.1M | 52k | 98.40 |
| 2017-12-31 | $5.3M | 51k | 104.87 |
| 2017-09-30 | $13M | 115k | 112.42 |
| 2017-06-30 | $13M | 112k | 114.29 |
| 2017-03-31 | $25M | 126k | 200.00 |
| 2016-12-31 | $13M | 122k | 105.00 |
| 2016-09-30 | $12M | 104k | 110.77 |
| 2016-06-30 | $16M | 113k | 145.33 |
| 2016-03-31 | $10M | 70k | 144.00 |
| 2015-12-31 | $10M | 66k | 154.00 |
| 2015-09-30 | $1.7M | 12k | 142.91 |
| 2015-06-30 | $265k | 1.8k | 143.63 |
| 2015-03-31 | $2.4M | 17k | 140.92 |
| 2014-12-31 | $2.8M | 19k | 147.97 |
| 2014-09-30 | $3.4M | 22k | 153.93 |
| 2014-06-30 | $259k | 1.8k | 140.38 |
Top funds holding Taro Pharmaceutical Industries
View all funds holding Taro Pharmaceutical Industries